What is the equivalent formulation or dosing regimen for a losartan 100 mg/hydrochlorothiazide 25 mg tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Losartan 100 mg/HCTZ 25 mg: Equivalent Formulations

Losartan 100 mg/hydrochlorothiazide 25 mg is available as a single fixed-dose combination tablet and represents the maximum strength formulation of this combination. 1

Available Formulations

The losartan/HCTZ combination comes in standardized fixed-dose tablets:

  • Losartan 50 mg/HCTZ 12.5 mg (lower strength)
  • Losartan 100 mg/HCTZ 25 mg (higher strength - your current dose)

These are the only two FDA-approved fixed-dose combinations 1. The 100/25 mg formulation is supplied as round, green film-coated tablets.

Dosing Equivalence

If you're asking about component equivalence (taking separate tablets instead of the combination):

  • Losartan 100 mg tablet (taken separately) + HCTZ 25 mg tablet (taken separately) = Losartan/HCTZ 100/25 mg combination tablet

However, fixed-dose combinations are strongly preferred because they improve medication adherence and simplify the regimen 2.

Clinical Context from Guidelines

The 2025 AHA/ACC guidelines recommend the combination of ARB (like losartan) + thiazide diuretic as a preferred initial regimen for hypertension 3. For resistant hypertension specifically, guidelines suggest replacing standard HCTZ with chlorthalidone 12.5-25 mg or indapamide 1.25-2.5 mg due to their superior efficacy and longer half-life 3.

Alternative Consideration: Losartan/Chlorthalidone

If blood pressure remains uncontrolled on losartan/HCTZ 100/25 mg, losartan 100 mg/chlorthalidone 25 mg may be more effective. Recent evidence shows chlorthalidone provides superior diastolic blood pressure reduction and higher rates of achieving target blood pressure compared to HCTZ at equivalent doses 4. Chlorthalidone is specifically preferred in guidelines for resistant hypertension 3.

Efficacy Data

The losartan/HCTZ 100/25 mg combination produces:

  • Mean SBP/DBP reduction: 17.5/9.0 mmHg compared to baseline 5
  • Response rate: 86.7% of patients achieve blood pressure control 5
  • Superior efficacy compared to the 50/12.5 mg dose, with additional reductions of approximately 5-6 mmHg systolic 6

Common pitfall: Some clinicians continue increasing losartan alone beyond 50 mg, but adding HCTZ 12.5 mg to losartan 50 mg produces greater blood pressure reduction (15.5/9.2 mmHg) than losartan monotherapy at any dose 1. The combination approach is more effective than dose escalation of a single agent.

Safety Profile

The 100/25 mg combination is well-tolerated with adverse event rates similar to placebo 5, 7. Monitor serum potassium and renal function, particularly in patients with chronic kidney disease, though metabolic parameters generally remain stable 7, 8.

References

Related Questions

My blood pressure is 142/95 mm Hg while taking losartan 100 mg and hydrochlorothiazide 25 mg; how should I manage it?
How should the fixed‑dose combination tablet of losartan 100 mg and hydrochlorothiazide 25 mg be prescribed, monitored, and what are its contraindications for an adult patient with hypertension?
In a patient on Losartan 100 mg daily and hydrochlorothiazide 25 mg daily who still has blood pressure 177/110 mm Hg, how should the hypertension be managed?
What is the next treatment option for a 53-year-old male with hypertension currently taking losartan 100 mg daily, hydralazine 10 mg every 8 hours, and hydrochlorothiazide 25 mg daily?
Why should losartan‑hydrochlorothiazide be held in an inpatient setting?
What treatment options would you recommend for a 54-year-old patient with chronic depression who has already tried a medication (e.g., somant) and is seeking advice?
What are the contraindications for performing a resuscitative thoracotomy?
How is the oxybutynin transdermal patch used to treat overactive bladder, including dosing, application site, and contraindications?
Can hypothyroidism lead to diabetes (type 2)?
In a patient with persistently elevated sex hormone‑binding globulin (SHBG) and elevated testosterone, and no identifiable disease, medication effect, or imaging abnormalities, should genetic testing for SHBG‑related polymorphisms be pursued to assess a possible hereditary protein‑binding disorder?
What is the significance of a low-level M‑spike (0.3 g/dL) on serum protein electrophoresis with otherwise normal results, and what evaluation and monitoring are recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.